Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL18045530

CCCCc1ccc([N+](=O)[O-])cc1.N

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.65
▸ TSHR P16473 1/20 0.58
▸ KCNJ1 P48048 2/20 0.54
▸ MAPT P10636 1/20 0.53
▸ LOXL2 Q9Y4K0 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ FAAH O00519 1/20 0.49
▸ MGLL Q99685 1/20 0.49
▸ SIGMAR1 Q99720 1/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.49
▸ EIF4A1 P60842 1/20 0.48
▸ STING1 Q86WV6 1/20 0.48
▸ PLK1 P53350 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4737258 0.98 KCNH2 (0.67) KCNH2TSHRKCNJ1MAPTLOXL2
Ammonia Solution, Strong SCHEMBL16497027 0.93 KCNH2 (0.75) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL680595 0.92 KCNH2 (0.74) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL8743949 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL11075250 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL25174460 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL6678908 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL4310058 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL1881781 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2
SCHEMBL25171490 0.91 KCNH2 (0.77) KCNH2TSHRKCNJ1MAPTLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110950781-A Novel diamine, polyamic acid, and polyimide 日产化学工业株式会社 2020-04-03 — — CN disclosed
US-10023530-B2 Diamine, polyamic acid, and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-07-17 — — US disclosed
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES. LTD. (JP) 2016-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023530-B2 Diamine, polyamic acid, and polyimide H1-2, H1-4, H1-0 KCNH2 3803/4885TSHR 2393/4885KCNJ1 4460/4885
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE H1-4, H1-2, H1-5 KCNH2 3737/4885TSHR 3020/4885KCNJ1 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback